Technical Analysis for TNXP - Tonix Pharmaceuticals Holding Corp.

Grade Last Price % Change Price Change
grade F 2.54 -5.93% -0.16
TNXP closed down 5.93 percent on Monday, November 11, 2019, on 2.65 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The bears made the stock sink to a new 52-week low. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical TNXP trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Hammer Candlestick Bullish 0.00%
Lizard Bullish Bullish Day Trade Setup 0.00%
NR7 Range Contraction 0.00%
Doji - Bullish? Reversal 0.00%
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%

Older signals for TNXP ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Tonix Pharmaceuticals Holding Corp., a development stage specialty pharmaceutical company, focuses on the development of pharmaceutical products for the disorders of central nervous system. The company's lead product candidate includes TNX-102 SL, a dose and formulation of cyclobenzaprine for the treatment of fibromyalgia and post-traumatic stress disorder. It also has a pipeline of various other product candidates, including TNX-201, which is a treatment for certain types of headaches; and TNX-301. The company was founded in 2007 and is headquartered in New York, New York.
Health Drugs Pharmaceutical Products Disorders Health Sciences Fibromyalgia Stage Specialty Pharmaceutical Post Traumatic Stress Disorder Seth Lederman
Is TNXP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 96.0
52 Week Low 2.25
Average Volume 59,220
200-Day Moving Average 13.4015
50-Day Moving Average 4.1265
20-Day Moving Average 3.6141
10-Day Moving Average 3.0613
Average True Range 0.5605
ADX 26.22
+DI 6.3542
-DI 14.7578
Chandelier Exit (Long, 3 ATRs ) 3.3185
Chandelier Exit (Short, 3 ATRs ) 3.9315
Upper Bollinger Band 4.9665
Lower Bollinger Band 2.2617
Percent B (%b) 0.1
BandWidth 74.840209
MACD Line -0.4443
MACD Signal Line -0.3524
MACD Histogram -0.092
Fundamentals Value
Market Cap 19.07 Million
Num Shares 7.51 Million
EPS -5.68
Price-to-Earnings (P/E) Ratio -0.45
Price-to-Sales 0.00
Price-to-Book 0.83
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.04
Resistance 3 (R3) 2.99 2.79 2.95
Resistance 2 (R2) 2.79 2.66 2.81 2.92
Resistance 1 (R1) 2.66 2.58 2.56 2.71 2.90
Pivot Point 2.46 2.46 2.41 2.48 2.46
Support 1 (S1) 2.33 2.33 2.23 2.38 2.18
Support 2 (S2) 2.13 2.25 2.15 2.16
Support 3 (S3) 2.00 2.13 2.13
Support 4 (S4) 2.05